1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249.
2D'Agostino J,Zhang XL,Wu H,et al.Characterization of CYP2A13*2,a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers[J].Drug Metab Dispos,2008,36(11):2316-2323.
3Ozturk O,Isbir T,Yaylim I,et al.GSTM1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell lung carcinomas[J].In viro,2003,17 (6):625-632.
5Tetsuya K,Masaki F,Kazuma K,et al.Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco - related cancer risk[J].Biochem Biophys Res Commun,2005,338 (1):306-310.
9Cote ML,Chen W,Smith DW,et al.Meta-and pooled analysis of GSTP1 polymorphism and lung cancer:a HuGE-GSEC review[J].Am J Epidemiol,2009,169(7):802-814.
10Wang J,Deng Y,Cheng J,et al.GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population[J].Cancer Lett,2003,201(2):195-193.
5Ekstrom G, Ingelman-Sundberg M. Rat liver microsomalNADPH-supported oxidase activity and lipid peroxida-tion dependent on ethanol-inducible cytochromeP450 (P-450IIE1). Biochem Pharmacol, 1989, 38:1313
6Strange R C, Lear J T, Fryer A A et al. Glutathione S-transferase polymorphisms., influence on susceptibility tocancer. Chem Biol Interact, 1998, 111.. 351
7Yu M W, Gladek Yarborough, Chiamprasert S et al.Cytochrome P450 2El and glutathione S-transferase M1polymorphisms and susceptibility to hepatocellular carci-noma. Gastroenterol, 1995, 109:1266
8Lucas D, Menez C, Girre C et al. Cytochrome P4502E1genotype and chlorzoxazone metabolism in healthy andalcoholic caucasian subjects. Pharmacogenetics, 1995, 5:298
9Wang S L, Lee H, Chen K W et al. CytochromeP4502E1 genetic polymorphisms and lung cancer in aTaiwan Residents population. Lung cancer, 1999, 26:27
10Lin D X, Tang Y M, Peng Q et al. SusceptibiliTy toesophagel cancer and genetic polymorphisms in glu-tathione S-transferase T1, PI, M1 and Cytochrome P4502El. Cancer Epidemiol Biomark Prev, 1998, 7:1013
